PHARMATECH, INC.

Basic Information

789 SHERMAN STREET
SUITE 600
DENVER, CO, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 622484244
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials

    Amount: $1,652,174.00

    DESCRIPTION (provided by applicant): The American Cancer Society estimates that more than 1.5 million new cancer victims will be diagnosed this year in the U.S., and that ~572,000 Americans will die o ...

    SBIR Phase II 2012 Department of Health and Human Services
  2. A Patient-Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials

    Amount: $154,707.00

    DESCRIPTION (provided by applicant): Our new president vows to address the pervasive issue of cancer. Over 1.4 million Americans will be diagnosed with cancer this year, joining over 10 million living ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government